PT1244650E - Derivados arilaminas e sua aplicacao como agentes anti-telomerase - Google Patents
Derivados arilaminas e sua aplicacao como agentes anti-telomeraseInfo
- Publication number
- PT1244650E PT1244650E PT00985339T PT00985339T PT1244650E PT 1244650 E PT1244650 E PT 1244650E PT 00985339 T PT00985339 T PT 00985339T PT 00985339 T PT00985339 T PT 00985339T PT 1244650 E PT1244650 E PT 1244650E
- Authority
- PT
- Portugal
- Prior art keywords
- arillamine
- derivatives
- application
- agents
- telomerase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9915031A FR2801588B1 (fr) | 1999-11-29 | 1999-11-29 | Derives chimiques et leur application comme agent antitelomerase |
| FR0010561 | 2000-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1244650E true PT1244650E (pt) | 2003-11-28 |
Family
ID=26212577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00985339T PT1244650E (pt) | 1999-11-29 | 2000-11-27 | Derivados arilaminas e sua aplicacao como agentes anti-telomerase |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1244650B1 (pt) |
| JP (1) | JP2003515604A (pt) |
| KR (1) | KR20020058043A (pt) |
| CN (1) | CN1402722A (pt) |
| AT (1) | ATE243692T1 (pt) |
| AU (1) | AU2179001A (pt) |
| BG (1) | BG106753A (pt) |
| BR (1) | BR0015992A (pt) |
| CA (1) | CA2392507A1 (pt) |
| CO (1) | CO5251431A1 (pt) |
| CZ (1) | CZ20021849A3 (pt) |
| DE (1) | DE60003583T2 (pt) |
| DK (1) | DK1244650T3 (pt) |
| EA (1) | EA200200616A1 (pt) |
| EE (1) | EE200200263A (pt) |
| ES (1) | ES2202206T3 (pt) |
| HU (1) | HUP0204429A2 (pt) |
| IL (1) | IL149402A0 (pt) |
| MX (1) | MXPA02005276A (pt) |
| NO (1) | NO20022528L (pt) |
| PE (1) | PE20010912A1 (pt) |
| PL (1) | PL355667A1 (pt) |
| PT (1) | PT1244650E (pt) |
| SK (1) | SK7402002A3 (pt) |
| UY (1) | UY26456A1 (pt) |
| WO (1) | WO2001040218A1 (pt) |
| YU (1) | YU38102A (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2306671T3 (es) | 1999-10-07 | 2008-11-16 | Amgen Inc. | Inhibidores de triazina quinasa. |
| WO2001055116A2 (en) * | 2000-01-28 | 2001-08-02 | Astrazeneca Ab | Quinoline derivatives and their use as aurora 2 kinase inhibitors |
| CN1429222A (zh) | 2000-02-17 | 2003-07-09 | 安姆根有限公司 | 激酶抑制剂 |
| WO2002012194A1 (fr) * | 2000-08-08 | 2002-02-14 | Aventis Pharma S.A. | Derives de phenanthridine et leur application comme agents antitelomerases |
| ES2324981T3 (es) | 2000-12-21 | 2009-08-21 | Smithkline Beecham Corporation | Pirimidinaminas como moduladores de la angiogenesis. |
| FR2821355A1 (fr) * | 2001-02-23 | 2002-08-30 | Aventis Pharma Sa | Derives chimiques et leur application comme agent antitelomerase |
| US6887873B2 (en) | 2001-03-23 | 2005-05-03 | Aventis Pharma S.A. | Triazine derivatives and their application as antitelomerase agents |
| CO5380035A1 (es) * | 2001-03-23 | 2004-03-31 | Aventis Pharma Sa | Derivados quimicos y su aplicacion como agente antitelomerasa |
| FR2822468B1 (fr) * | 2001-03-23 | 2008-06-20 | Aventis Pharma Sa | Derives chimiques et leur application comme agent anti-telomerase |
| WO2002096903A2 (fr) * | 2001-05-28 | 2002-12-05 | Aventis Pharma S.A. | Derives chimiques et leur application comme agent antitelomerase |
| US6939874B2 (en) * | 2001-08-22 | 2005-09-06 | Amgen Inc. | Substituted pyrimidinyl derivatives and methods of use |
| US7115617B2 (en) | 2001-08-22 | 2006-10-03 | Amgen Inc. | Amino-substituted pyrimidinyl derivatives and methods of use |
| US7163943B2 (en) | 2001-09-21 | 2007-01-16 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7169785B2 (en) | 2001-09-21 | 2007-01-30 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7112587B2 (en) | 2001-09-21 | 2006-09-26 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7173032B2 (en) | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7132423B2 (en) | 2001-09-21 | 2006-11-07 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| AU2002352878B2 (en) | 2001-11-27 | 2007-11-22 | Merck Sharp & Dohme Corp. | 2-Aminoquinoline compounds |
| WO2004024711A1 (en) * | 2002-09-10 | 2004-03-25 | Pharmacia Italia S.P.A. | Substituted pyridine derivatives as antitumor agent |
| AU2003275726A1 (en) * | 2002-10-24 | 2004-05-13 | Chong Kun Dang Pharmaceutical Corp. | 2 - substituted heterocyclic compounds and antitumor composition comprising the same |
| FR2850970B1 (fr) * | 2003-02-07 | 2006-07-07 | Aventis Pharma Sa | Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique |
| JP4691041B2 (ja) * | 2003-11-20 | 2011-06-01 | チルドレンズ ホスピタル メディカル センター | Ｇｔｐアーゼ阻害剤および使用方法 |
| US7335770B2 (en) | 2004-03-24 | 2008-02-26 | Reddy U5 Therapeutics, Inc. | Triazine compounds and their analogs, compositions, and methods |
| CA2627628A1 (en) | 2005-10-28 | 2007-05-03 | Iti Scotland Limited | Novel fluorescent dyes and uses thereof |
| US7713987B2 (en) | 2005-12-06 | 2010-05-11 | Rigel Pharmaceuticals, Inc. | Pyrimidine-2,4-diamines and their uses |
| KR100761869B1 (ko) * | 2006-07-07 | 2007-10-04 | 김현기 | 트리아진 유도체 화합물 및 이를 포함하는 암 치료용조성물 |
| JP2009545592A (ja) * | 2006-07-31 | 2009-12-24 | プリーシス・ファーマシューティカルズ・インコーポレイテッド | コード化小分子ライブラリーからのオーロラキナーゼ阻害剤 |
| JP5325517B2 (ja) * | 2007-10-12 | 2013-10-23 | 住友化学株式会社 | ジベンゾオキセピン化合物の精製方法 |
| JP2009102249A (ja) * | 2007-10-22 | 2009-05-14 | Sumitomo Chemical Co Ltd | ジベンゾオキセピン化合物の結晶の製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
| US5770613A (en) * | 1995-09-29 | 1998-06-23 | Geron Corporation | Telomerase inhibitors |
| JPH1160573A (ja) * | 1997-08-22 | 1999-03-02 | Nippon Kayaku Co Ltd | トリアジン誘導体及びテロメラーゼ阻害剤 |
| EP1053237B1 (en) * | 1998-02-04 | 2003-07-02 | The Board Of Regents, The University Of Texas System | Inhibition of human telomerase by a g-quadruplex-interaction compound |
| DE19812879A1 (de) * | 1998-03-24 | 1999-09-30 | Bayer Ag | Substituierte 2,4-Diamino-1,3,5-triazine |
-
2000
- 2000-11-27 CZ CZ20021849A patent/CZ20021849A3/cs unknown
- 2000-11-27 CN CN00816440A patent/CN1402722A/zh active Pending
- 2000-11-27 WO PCT/FR2000/003310 patent/WO2001040218A1/fr not_active Application Discontinuation
- 2000-11-27 IL IL14940200A patent/IL149402A0/xx unknown
- 2000-11-27 DK DK00985339T patent/DK1244650T3/da active
- 2000-11-27 PL PL00355667A patent/PL355667A1/xx not_active Application Discontinuation
- 2000-11-27 BR BR0015992-1A patent/BR0015992A/pt not_active IP Right Cessation
- 2000-11-27 MX MXPA02005276A patent/MXPA02005276A/es unknown
- 2000-11-27 CA CA002392507A patent/CA2392507A1/fr not_active Abandoned
- 2000-11-27 AT AT00985339T patent/ATE243692T1/de not_active IP Right Cessation
- 2000-11-27 JP JP2001541902A patent/JP2003515604A/ja not_active Withdrawn
- 2000-11-27 EE EEP200200263A patent/EE200200263A/xx unknown
- 2000-11-27 EP EP00985339A patent/EP1244650B1/fr not_active Expired - Lifetime
- 2000-11-27 PT PT00985339T patent/PT1244650E/pt unknown
- 2000-11-27 HU HU0204429A patent/HUP0204429A2/hu unknown
- 2000-11-27 SK SK740-2002A patent/SK7402002A3/sk unknown
- 2000-11-27 DE DE60003583T patent/DE60003583T2/de not_active Expired - Fee Related
- 2000-11-27 KR KR1020027006786A patent/KR20020058043A/ko not_active Application Discontinuation
- 2000-11-27 AU AU21790/01A patent/AU2179001A/en not_active Abandoned
- 2000-11-27 EA EA200200616A patent/EA200200616A1/ru unknown
- 2000-11-27 ES ES00985339T patent/ES2202206T3/es not_active Expired - Lifetime
- 2000-11-27 YU YU38102A patent/YU38102A/sh unknown
- 2000-11-28 PE PE2000001265A patent/PE20010912A1/es not_active Application Discontinuation
- 2000-11-28 CO CO00090981A patent/CO5251431A1/es not_active Application Discontinuation
- 2000-11-28 UY UY26456A patent/UY26456A1/es not_active Application Discontinuation
-
2002
- 2002-05-28 NO NO20022528A patent/NO20022528L/no not_active Application Discontinuation
- 2002-05-29 BG BG106753A patent/BG106753A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001040218A1 (fr) | 2001-06-07 |
| DE60003583T2 (de) | 2004-05-13 |
| KR20020058043A (ko) | 2002-07-12 |
| CN1402722A (zh) | 2003-03-12 |
| AU2179001A (en) | 2001-06-12 |
| CA2392507A1 (fr) | 2001-06-07 |
| CZ20021849A3 (cs) | 2002-08-14 |
| PL355667A1 (en) | 2004-05-04 |
| EA200200616A1 (ru) | 2002-10-31 |
| HUP0204429A2 (hu) | 2003-04-28 |
| DK1244650T3 (da) | 2003-10-20 |
| PE20010912A1 (es) | 2001-09-01 |
| IL149402A0 (en) | 2002-11-10 |
| MXPA02005276A (es) | 2002-11-07 |
| EE200200263A (et) | 2003-06-16 |
| YU38102A (sh) | 2004-12-31 |
| EP1244650B1 (fr) | 2003-06-25 |
| CO5251431A1 (es) | 2003-02-28 |
| ES2202206T3 (es) | 2004-04-01 |
| DE60003583D1 (de) | 2003-07-31 |
| UY26456A1 (es) | 2001-06-29 |
| JP2003515604A (ja) | 2003-05-07 |
| NO20022528D0 (no) | 2002-05-28 |
| NO20022528L (no) | 2002-05-28 |
| ATE243692T1 (de) | 2003-07-15 |
| BR0015992A (pt) | 2002-08-06 |
| SK7402002A3 (en) | 2002-11-06 |
| BG106753A (bg) | 2003-02-28 |
| EP1244650A1 (fr) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1244650E (pt) | Derivados arilaminas e sua aplicacao como agentes anti-telomerase | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| CY1118480T1 (el) | Παραγωγα toy uk-2a | |
| ATE231872T1 (de) | Thiazolopyrimidinderivate | |
| DE69925133D1 (de) | Pyrrolobenzodiazepine | |
| BRPI0411617A (pt) | derivados de pirimidina como ligantes de receptores de canabinóides | |
| PT797439E (pt) | Utilizacao de pramipexote como agente neuroprotector | |
| CY1110721T1 (el) | Χρηση glp-2 σε συνδυασμο με αλλο θεραπευτικο παραγοντα σε οστικες παθησεις | |
| DE60112974D1 (en) | Carbolinderivate | |
| SG145695A1 (en) | Pyridyl derivatives and their use as therapeutic agents | |
| AR027355A1 (es) | Acidos tiazolidincarboxilicos | |
| WO2002096903A3 (fr) | Derives chimiques et leur application comme agent antitelomerase | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| CY2008007I2 (el) | Χρηση του et743 στην συνδυαστικη θεραπεια με δεξαμεθαζονη για την θεραπευτικη αγωγη του καρκινου | |
| NO20022692L (no) | Terapeutiske midler | |
| DE60216233D1 (en) | Carbolinderivate | |
| HK1076812A1 (en) | Cyanoguanidine prodrugs | |
| SE9904377D0 (sv) | Pharmaceutical combinations | |
| SE0301650D0 (sv) | Novel compounds | |
| DE60206599D1 (de) | Biotin-derivate und ihre konjugaten mit chelatierungsmitteln | |
| NO20005548L (no) | Mykobakterieinhibitorer | |
| NO20016301D0 (no) | Terapeutiske midler | |
| PT1224181E (pt) | Pirrois substituidos uteis como agentes antiproliferativos para o tratamento do cancro | |
| MXPA04005226A (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion. | |
| DE10157913B4 (de) | Therapietisch |